CardioBites: SGLT2is Series

Overview - What are CardioBites

CardioBites are mobile-friendly, bite-sized videos producting focused education on important topics in the heart failure field. They can be watch anytime, anywhere on YouTube. No password. No barriers. Just easy access. HFSA will release one CardioBites video each month.

Simply click on the image below to view the episodes and subscribe to the HFSA YouTube channel.

View the full playlist of videos in this series here.

Target Audience

The CardioBites Video Series is designed to educate physicians, scientists, nurses, nurse practitioners, pharmacists and patients about the recent advances in emerging trends in Heart Failure.

Series Outline

CardioBites: SGLT2is: Understanding the buden of heart failure

Heart failure affects some 6.7 million Americans over 20 years of age. This number is expected to grow to 8.5 million in the next 6 years. In this module, we explore the burden heart failure places on morbidity, mortality, and hospitalization.
YouTube Link

Current guidelines on the use of sodium-glucose cotransporter-2 inhibitors (SGLT2is) in heart failure
Sodium-glucose cotransporter-2 inhibitors (SGLT2is), were originally intended as a diabetes medication, but have also been helpful in treatment heart failure. Learn more about SGLT2i therapy and it can help your patients with this condition.
YouTube Link

The impact of Hospital Readmissions on Health-Related Quality of Life in Heart Failure
Hospital readmission for heart failure increases costs and the risks of morbidity and mortality. In this video, we exam how readmissions negatively impacts the patient's health-related quality of life.
YouTube Link

Improving the Transition of Care in Heart Failure
How a patient transition from one level of care to another can affect their outcomes and enhance their quality of life. In this video, we explore how we can facilitate transfer of care and help address our patients' specific needs as they move from one level of care to another.
YouTube Link

Why Guideline-Directed Medical Therapy in Heart Failure Matters
Current guidelines for heart failure with reduced ejection fraction recommend the initiation and optimization of guideline-directed medical therapy to improve patient outcomes. In this video, we review why GDMT in heart failure matters.
YouTube Link

Understanding the Burden of Heart Failure Infographic
The PDF Infographic

CardioBites FAQs

Bite-sized videos, focus education frequently asked questions.

HFSA YouTube Channel

Subscribe to the HFSA YouTube channel.

Supporter(s)

The Heart Failure Society of America acknowledges Lexicon Pharmaceuticals, Inc. for providing an independent educational grant to support the HFSA CardioBites: SGLT2is.

Summary


Cost:	FREE


Credit:	No Credit Offered

Create Account

Recommended

Heart Failure: Diagnostic Testing and Advanced Therapies

No Credit

FREE

Heart Failure: Medications and Challenges of Multiple Medications

No Credit

FREE

Heart Failure Seminar: Updates in Advanced Heart Failure, LVAD Is In Place, Now What? Current Thoughts on Antithrombetic Therapy

Multiple Credits

$0.00 - $59.00

CardioBites: Amyloidosis Series

No Credit

FREE

HFSA HF-Cert Bootcamp OnDemand

Credits for CME, NCPD, CPE and AAPA has been accredited for 4.0.

Multiple Credits

$99.00 - $199.00

CardioBites:HFpEF Series

No Credit

FREE

Heart Failure: Managing Heart Failure & Diabetes

No Credit

FREE

Heart Failure Seminar: Focus on Cognitive Impairment

Multiple Credits

FREE

CardioBites: Congestion

No Credit

FREE

Heart Failure Seminar: Focus on Novel and Emerging Myocarditides: Recognition and Management

Multiple Credits

$0.00 - $59.00